| Stage | DGX | % of rev | BLLN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.1B | 100.00% | $123M | 100.00% | DGX ×25.18 |
| Gross profit | $1.0B | 33.65% | $87M | 70.86% | BLLN +37.2pp |
| Operating income | $479M | 15.47% | $11M | 8.96% | DGX +6.5pp |
| Pre-tax income | $416M | 13.43% | $17M | 14.14% | BLLN +0.7pp |
| Net income | $326M | 10.53% | $17M | 14.14% | BLLN +3.6pp |
| Stage | DGX | BLLN | Gap · A − B |
|---|---|---|---|
| Revenue | $3.1B100.00% | $123M100.00% | DGX ×25.18 |
| Gross profit | 33.65%$1.0B | 70.86%$87M | BLLN +37.2pp |
| Operating income | 15.47%$479M | 8.96%$11M | DGX +6.5pp |
| Pre-tax income | 13.43%$416M | 14.14%$17M | BLLN +0.7pp |
| Net income |
| 10.53%$326M |
| 14.14%$17M |
| BLLN +3.6pp |
No shared counterparties.